Cardiovascular Diseases

24-Hour and Nighttime BP Linked to CVD Risk

A longitudinal population-based cohort study showed that higher 24-hour and nighttime blood pressure (BP) measurements were significantly associated with greater risks of death and a composite cardiovascular (CV) outcome. The study included 11 135 adults from Europe, Asia, and South America (median age, 54.7 years, 49.3% women) with baseline observations collected from May 1988 to May 2010, 2836 participants died and 2049 experienced a CV event over a median of 13.8 years of follow-up. Both CV mortality and the composite of nonfatal coronary events, heart failure, and stroke were significantly associated with all single systolic BP indexes. For nighttime systolic BP level, the hazard ratio (HR) for total mortality was 1.23 and for CV events, 1.36. For the 24-hour systolic BP level, the HR for total mortality was 1.22 and for CV events, 1.45. With adjustment for any of the other systolic BP indexes, the associations of nighttime and 24-hour systolic BP with the primary outcomes remained statistically significant. Adding any systolic BP index to models already including nighttime or 24-hour systolic BP did not significantly improve model performance. Findings were consistent for diastolic BP. The findings suggest that 24-hour and nighttime BP may be considered optimal measurements for estimating CV risk and could be used to justify treatment of BP that is above the treatment threshold. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Mindfulness-Based Stress Reduction on Par with Escitalopram for Anxiety Disorders

Both clinician-rated and patient-reported outcomes suggested that mindfulness-based stress reduction (MBSR) was well-tolerated with comparable…

4 days ago

Key Messages of 2024 ESC Guidelines for High BP

The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of…

1 month ago

CRP, LDL Cholesterol, and Lipoprotein(a) Levels Predictive of CVD

A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a)…

1 month ago

No Benefit to Stop Beta-Blockers After MI

A French multicenter, open label, randomized, noninferiority trial suggested that interruption of long-term beta-blocker treatment…

2 months ago

Plant vs Animal Fat on Mortality

A US prospective cohort study demonstrated that replacement of animal fat with an equivalent amount…

2 months ago

UK T2D Remission Program Findings

An ongoing UK national prospective program shows remission of type 2 diabetes (T2D) outside of…

2 months ago

This website uses cookies.